🌎 prevalence of MASLD 30%
⬆️ risk progression with DM, HTN, obesity, menopause
Screen for 🍷
♻️ Putative connection between MASLD, CVD, CKD
🌎 prevalence of MASLD 30%
⬆️ risk progression with DM, HTN, obesity, menopause
Screen for 🍷
♻️ Putative connection between MASLD, CVD, CKD
@juanpabloarab.bsky.social @saulkarpen.bsky.social @vculiver.bsky.social
@juanpabloarab.bsky.social @saulkarpen.bsky.social @vculiver.bsky.social
Kudos to the organisers @juanpabloarab.bsky.social, Dr Noureddin and team!
#HepatologySky
Kudos to the organisers @juanpabloarab.bsky.social, Dr Noureddin and team!
#HepatologySky
pubmed.ncbi.nlm.nih.gov/39734389/
High-yield flowchart for management of ICIC included!
#GISky
pubmed.ncbi.nlm.nih.gov/39734389/
High-yield flowchart for management of ICIC included!
#GISky
@amcollegegastro.bsky.social #VCUHealth
@amcollegegastro.bsky.social #VCUHealth
⤵️ infections, hospitalizations with rapid taper
💫 changing practice in management of AAH
#LiverSky #AASLD
⤵️ infections, hospitalizations with rapid taper
💫 changing practice in management of AAH
#LiverSky #AASLD
Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky
Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky